
MetalDrug is a molecular design platform that combines coordination chemistry with computational logic to create programmable therapeutic compounds with high precision and control. It offers a logic-first design approach with structured simulations based on interaction logic across redox states, pH variations, and electrostatic dynamics, enabling traceable and auditable molecular blueprints. The company provides integrated platforms including Metal Drug Complex (MDC) for metal-ligand therapeutic design, Functional Drug Complex (FDC) for peptide, RNA, and ligand programming, and the Moleculogic Simulation Platform for unified logic-driven modeling and validation. MetalDrug serves biopharma companies, academic researchers, biotech startups, therapeutic alliances, synthetic biology teams, and regulatory teams with tiered access licensing and simulation infrastructure to accelerate therapeutic development and ensure ethical, reproducible molecular design.

MetalDrug is a molecular design platform that combines coordination chemistry with computational logic to create programmable therapeutic compounds with high precision and control. It offers a logic-first design approach with structured simulations based on interaction logic across redox states, pH variations, and electrostatic dynamics, enabling traceable and auditable molecular blueprints. The company provides integrated platforms including Metal Drug Complex (MDC) for metal-ligand therapeutic design, Functional Drug Complex (FDC) for peptide, RNA, and ligand programming, and the Moleculogic Simulation Platform for unified logic-driven modeling and validation. MetalDrug serves biopharma companies, academic researchers, biotech startups, therapeutic alliances, synthetic biology teams, and regulatory teams with tiered access licensing and simulation infrastructure to accelerate therapeutic development and ensure ethical, reproducible molecular design.